↓ Skip to main content

Effectiveness of dexmedetomidine for emergence agitation in infants undergoing palatoplasty: a randomized controlled trial

Overview of attention for article published in Brazilian Journal of Anesthesiology (English edition), January 2016
Altmetric Badge

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effectiveness of dexmedetomidine for emergence agitation in infants undergoing palatoplasty: a randomized controlled trial
Published in
Brazilian Journal of Anesthesiology (English edition), January 2016
DOI 10.1016/j.bjane.2015.01.001
Pubmed ID
Authors

Aiji Boku, Hiroshi Hanamoto, Aiko Oyamaguchi, Mika Inoue, Yoshinari Morimoto, Hitoshi Niwa

Abstract

In infants, there is a high incidence of emergence agitation (EA) after sevoflurane (Sev) anesthesia. This study aimed to test the hypothesis that dexmedetomidine (Dex) administration would reduce the incidence and severity of EA after Sev-based anesthesia in infants undergoing palatoplasty. A prospective randomized clinical trial was conducted with 70 patients undergoing palatoplasty, aged 10-14 months. Infants were randomly allocated into two groups: Dex (n=35) and saline (n=35). In the Dex group, Dex (6μg/kg/h) was administered approximately 10min before the end of the surgery for 10min, followed by 0.4μg/kg/h until 5min after extubation. In the saline group, an equivalent amount of saline was administered in a similar manner. After the surgery, patients were transferred to the postanesthetic care unit (PACU). The infant's behavior and pain were assessed with scoring system for EA (5-point rating scale) and pain scale (PS; 10-point rating scale), respectively. EA and PS were estimated at six time points (after extubation, leaving the operating room, 0, 30, 60, and 120min after arrival in PACU). EA and PS scores were significantly lower in the Dex group than in the saline group from extubation to 120min after arrival in PACU. Dex administration has the advantage of a reduced EA and PS without any adverse effects. Dex provided satisfactory recovery in infants undergoing palatoplasty.

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 26%
Student > Bachelor 9 14%
Student > Postgraduate 6 9%
Student > Doctoral Student 4 6%
Other 4 6%
Other 10 15%
Unknown 15 23%
Readers by discipline Count As %
Medicine and Dentistry 32 49%
Nursing and Health Professions 7 11%
Psychology 2 3%
Biochemistry, Genetics and Molecular Biology 1 2%
Agricultural and Biological Sciences 1 2%
Other 5 8%
Unknown 17 26%